FP7
DRIVE-AB
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 39 months
- Total cost
- EUR 10,968,676
- EU contribution
- EUR 6,299,987
- Participants
- 21 from 11 countries
- Topic
- FP7_IMI-JU-09-2013-03
- Grant agreement
- 115618
Coordinated by Astrazeneca AB (SESweden).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Astrazeneca AB | SESweden | Coordinator | Not stated | PIC (1.00) |
| Universiteit Antwerpen | BEBelgium | Participant | EUR 74,770 | known name (0.95) |
| Universite de Geneve | CHSwitzerland | Participant | EUR 1,670,756 | known name (0.95) |
| Eberhard Karls Universitaet Tuebingen | DEGermany | Participant | EUR 276,703 | PIC (1.00) |
| Ruprecht-Karls-Universitaet Heidelberg | DEGermany | Participant | EUR 56,817 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | Not stated | PIC (1.00) |
| Universite de Lorraine | FRFrance | Participant | EUR 130,403 | known name (0.95) |
| Astellas Pharma Europe Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| British Society for Antimicrobial Chemotherapy | GBUnited Kingdom | Participant | EUR 276,662 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| London School of Economics and Political Science | GBUnited Kingdom | Participant | EUR 91,078 | PIC (1.00) |
| The Royal Institute of International Affairs | GBUnited Kingdom | Participant | EUR 229,839 | PIC (1.00) |
| University of Strathclyde | GBUnited Kingdom | Participant | EUR 572,380 | known name (0.95) |
| Sveuciliste U Rijeci, Medicinski Fakultet | HRCroatia | Participant | EUR 24,300 | known name (0.95) |
| The Foundation for Medical Research Infrastructural Development and Health Services Next to the Medical Center Tel Aviv | ILIsrael | Participant | EUR 394,955 | PIC (1.00) |
| Stichting Radboud Universiteit | NLNetherlands | Participant | EUR 280,445 | known name (0.95) |
| Wageningen University | NLNetherlands | Participant | EUR 37,059 | known name (0.95) |
| Folkehelseinstituttet | NONorway | Participant | EUR 899,100 | known name (0.95) |
| Uppsala Universitet | SESweden | Participant | EUR 933,080 | known name (0.95) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | Not stated | PIC (1.00) |
| Name not shown | Not stated | Participant | Not stated | PIC (1.00) |
Changes of the consortium
First seen on with 21 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.